Literature DB >> 24692076

Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy.

Jianliang Shen1, Han-Cheon Kim, Chaofeng Mu, Emanuela Gentile, Junhua Mai, Joy Wolfram, Liang-nian Ji, Mauro Ferrari, Zong-wan Mao, Haifa Shen.   

Abstract

Cancer is a complex disease that usually requires several treatment modalities. A multifunctional nanotherapeutic system is designed, incorporating small interfering RNA (siRNA) and gold nanorods (Au NRs) for photothermal therapy. Surface-engineered Au NRs with polyethylenimine are synthesized using a layer-by-layer assembly and siRNA is absorbed on the surface. The siRNA is efficiently delivered into breast cancer cells, resulting in subsequent gene silencing. Cells are then irradiated with near-infrared (NIR) light, causing heat-induced anticancer activity. The combination of gene silencing and photothermal therapy results in effective inhibition of cell proliferation.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  gold nanorods; layer-by-layer assembly; photothermal therapy; siRNA

Mesh:

Substances:

Year:  2014        PMID: 24692076      PMCID: PMC4182177          DOI: 10.1002/adhm.201400103

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  29 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

2.  Solid lipid-PEI hybrid nanocarrier: an integrated approach to provide extended, targeted, and safer siRNA therapy of prostate cancer in an all-in-one manner.

Authors:  Hui-Yi Xue; Ho-Lun Wong
Journal:  ACS Nano       Date:  2011-08-18       Impact factor: 15.881

3.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

Review 4.  Gold nanostructures: engineering their plasmonic properties for biomedical applications.

Authors:  Min Hu; Jingyi Chen; Zhi-Yuan Li; Leslie Au; Gregory V Hartland; Xingde Li; Manuel Marquez; Younan Xia
Journal:  Chem Soc Rev       Date:  2006-09-06       Impact factor: 54.564

Review 5.  Gold nanoparticles in biomedical applications: recent advances and perspectives.

Authors:  Lev Dykman; Nikolai Khlebtsov
Journal:  Chem Soc Rev       Date:  2011-11-30       Impact factor: 54.564

Review 6.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

7.  Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.

Authors:  Yuling Xiao; Renata Jaskula-Sztul; Alireza Javadi; Wenjin Xu; Jacob Eide; Ajitha Dammalapati; Muthusamy Kunnimalaiyaan; Herbert Chen; Shaoqin Gong
Journal:  Nanoscale       Date:  2012-11-21       Impact factor: 7.790

8.  Breaking up the correlation between efficacy and toxicity for nonviral gene delivery.

Authors:  Miriam Breunig; Uta Lungwitz; Renate Liebl; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

9.  Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression.

Authors:  Michael S Goldberg; Phillip A Sharp
Journal:  J Exp Med       Date:  2012-01-23       Impact factor: 14.307

Review 10.  Interfering with disease: a progress report on siRNA-based therapeutics.

Authors:  Antonin de Fougerolles; Hans-Peter Vornlocher; John Maraganore; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

View more
  25 in total

1.  A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.

Authors:  Bronwyn Scott; Jianliang Shen; Sara Nizzero; Kathryn Boom; Stefano Persano; Yu Mi; Xuewu Liu; Yuliang Zhao; Elvin Blanco; Haifa Shen; Mauro Ferrari; Joy Wolfram
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

Review 2.  Nanoscale materials for hyperthermal theranostics.

Authors:  Bennett E Smith; Paden B Roder; Xuezhe Zhou; Peter J Pauzauskie
Journal:  Nanoscale       Date:  2015-04-28       Impact factor: 7.790

Review 3.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

Review 4.  Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.

Authors:  Ayesha Khalid; Joy Wolfram; Ilaria Ferrari; Chaofeng Mu; Junhua Mai; Zhizhou Yang; Yuliang Zhao; Mauro Ferrari; Xiaojing Ma; Haifa Shen
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

Review 5.  Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.

Authors:  Sara Busatto; Anthony Pham; Annie Suh; Shane Shapiro; Joy Wolfram
Journal:  Biomed Microdevices       Date:  2019-04-15       Impact factor: 2.838

6.  Solution Conditions Tune and Optimize Loading of Therapeutic Polyelectrolytes into Layer-by-Layer Functionalized Liposomes.

Authors:  Santiago Correa; Natalie Boehnke; Elad Deiss-Yehiely; Paula T Hammond
Journal:  ACS Nano       Date:  2019-04-18       Impact factor: 15.881

7.  A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.

Authors:  Jianliang Shen; Han-Cheon Kim; Joy Wolfram; Chaofeng Mu; Wei Zhang; Haoran Liu; Yan Xie; Junhua Mai; Hang Zhang; Zhi Li; Maria Guevara; Zong-Wan Mao; Haifa Shen
Journal:  Nano Lett       Date:  2017-04-21       Impact factor: 11.189

Review 8.  Safety of Nanoparticles in Medicine.

Authors:  Joy Wolfram; Motao Zhu; Yong Yang; Jianliang Shen; Emanuela Gentile; Donatella Paolino; Massimo Fresta; Guangjun Nie; Chunying Chen; Haifa Shen; Mauro Ferrari; Yuliang Zhao
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

9.  Cell source determines the immunological impact of biomimetic nanoparticles.

Authors:  Michael Evangelopoulos; Alessandro Parodi; Jonathan O Martinez; Iman K Yazdi; Armando Cevenini; Anne L van de Ven; Nicoletta Quattrocchi; Christian Boada; Nima Taghipour; Claudia Corbo; Brandon S Brown; Shilpa Scaria; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

10.  Hesperetin Liposomes for Cancer Therapy.

Authors:  Joy Wolfram; Bronwyn Scott; Kathryn Boom; Jianliang Shen; Carlotta Borsoi; Krishna Suri; Rossella Grande; Massimo Fresta; Christian Celia; Yuliang Zhao; Haifa Shen; Mauro Ferrari
Journal:  Curr Drug Deliv       Date:  2016       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.